Literature DB >> 16735789

Urinary metabolites of oxidative stress and nitric oxide in preterm and term infants.

Christiana R Farkouh1, Jeffrey D Merrill, Phillip L Ballard, Roberta A Ballard, Harry Ischiropoulos, Scott A Lorch.   

Abstract

BACKGROUND: Many neonatal diseases have been associated with oxidative stress and altered nitric oxide status.
OBJECTIVE: To determine the effects of clinical interventions on the levels of urinary peroxides, a marker of oxidative stress, and urinary nitrate/nitrites, indices of nitric oxide production and metabolism, in the first 72 h of life in premature infants.
METHODS: A single, spot urine sample was collected from 82 premature and 20 healthy term infants within the first 72 h of life. The peroxide levels were quantified using a fluorometric method, and nitrate/nitrite levels were quantified by chemiluminescence.
RESULTS: Premature infants had a median peroxide level of 10.0 micromol/mmol creatinine (Cr) (interquartile range 4.8-20.0 micromol/mmol Cr). These values were significantly higher than term infants (median 5.0 micromol/mmol Cr, interquartile range 2.7-10.0 micromol/mmol Cr). Urinary nitrate/nitrite levels were not significantly different between preterm (220.5 micromol/mmol Cr, interquartile range 161-287 micromol/mmol Cr) and healthy term infants (244 micromol/mmol Cr, interquartile range 194-316 micromol/mmol Cr). For urinary peroxides, infants on TPN had significantly higher urinary peroxide levels than infants who were not on TPN at the time of urine collection (p = 0.006). Administration of indomethacin was associated with lower levels of urinary nitrate/nitrites (p = 0.0003). Both effects remained significant after controlling for gestational age, degree of respiratory distress and day of urine collection.
CONCLUSION: Monitoring the level of both peroxides and nitrate/nitrite may offer added information about the degree of oxidative stress experienced by a newborn but needs to account for clinical and therapeutic interventions. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735789     DOI: 10.1159/000093633

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  6 in total

1.  Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome.

Authors:  Philip L Ballard; Roberta L Keller; Dennis M Black; David J Durand; Jeffrey D Merrill; Eric C Eichenwald; William E Truog; Mark C Mammel; Robin Steinhorn; Rita M Ryan; Sherry E Courtney; Hart Horneman; Roberta A Ballard
Journal:  Am J Perinatol       Date:  2014-06-26       Impact factor: 1.862

2.  Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia.

Authors:  Christiana W Davis; Linda W Gonzales; Roberta A Ballard; Philip L Ballard; Changjiang Guo; Andrew J Gow
Journal:  Pediatr Pulmonol       Date:  2008-07

3.  Early assessment of the severity of asphyxia in term newborns using parameters of blood count.

Authors:  Ingrid Brucknerová; Eduard Ujházy; Michal Dubovický; Mojmír Mach
Journal:  Interdiscip Toxicol       Date:  2008-12

Review 4.  A Scoping Review: Urinary Markers of Metabolic Maturation in Preterm Infants and Future Interventions to Improve Growth.

Authors:  Luise V Marino; Simone Paulson; James J Ashton; Charlotte Weeks; Aneurin Young; John V Pappachan; Jonathan Swann; Mark J Johnson; Robert Mark Beattie
Journal:  Nutrients       Date:  2022-09-23       Impact factor: 6.706

5.  Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Authors:  Asad I Mian; Mayank Aranke; Nathan S Bryan
Journal:  Open Biochem J       Date:  2013-03-08

6.  A Biomarker-Based Approach to Infectious Disease in the Pediatric Emergency Department.

Authors:  Mayank Aranke; Asad I Mian
Journal:  Clin Pediatr Emerg Med       Date:  2013-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.